Gladius Capital Management’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,620	Closed	-$34K	–	268
2024 Q2	$34K	Sell	2,620 -171	-6%	-$2.22K	﹤0.01%	147
2024 Q1	$48.7K	Buy	+2,791	New	+$48.7K	0.02%	126